Syngene acquires first US biologics facility for $36.5 million

Overall investment in the US facility is estimated around US$50 million

Lupin secures a place in S&P Global Sustainability Yearbook 2025

Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score

Sandeep Rao appointed MD and CEO of Solar Active Pharma Sciences

Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025

Lupin receives “A-” leadership rating from CDP in climate change and water security

This rating reflects Lupin's leadership in environmental transparency and performance

Roche appoints Wafaa Mamilli as Chief Digital Technology Officer

Mamilli last held the role of Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health at Zoetis

Alivus Life Sciences delivers 12% revenue growth

EBITDA margins expand to 31.3%

Ajooni Biotech to raise Rs. 45 crore through convertible warrants

These initiatives will strengthen the company’s capital base, providing financial flexibility for future

Aarti Drugs posts Q1 FY25 PAT lower at Rs. 33.3 Cr

Bayer aims to enhance performance and regain strategic flexibility by 2026

Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis

YS Biopharma appoints new Directors

The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024